Emergis Inc.

EME-T-DEAD

(A Top Pick Aug 8/07. Up 26%.) Was acquired by Telus (T-T).

(A Top Pick May 30/07. Up 27% at time of acquisition.) Acquired by Telus (T-T). For those now holding Telus, continue to hold.

(A Top Pick May 30/07. Up 27%.) Acquired by Telus (T-T).

March 29 2007, up 25% Then 6.42 Emergis, acquired by Telus.

(A Top Pick Mar 29/07. Up 29%.) Acquired by Telus (T-T). Sold his holdings at $8.15. Made a good gain.

Basically involved in health solutions by providing e-business solutions to a lot of the insurance and pharmacy companies and is showing decent growth. Very strong cash position. Earnings are looking at about $.31 for the year. Have been buying back stock and making some small tuck in acquisitions.

Provides back-office solution for some financial companies and health related companies. Just reported and numbers were good. Made a couple of acquisitions. Strong cash position. Earnings outlook is $.31 this year and should grow to $.43.

(A Top Pick July 25/06. Up 35%.) Recently added to his position. Has gone through a revolving door of management teams. New management is stable. Cheap.

Back-office settlement of pharmacy companies and health care operations. Have a major contracts with insurers. Likes the recurring revenue theme. Doing a good job of building new orders. Strong balance sheet.

Recurring revenue model. Focusing on the high-growth area. Earnings outlook continues to look good. Very strong balance sheet and close to $100 million in cash.

(A Top Pick July 25/06. Up 12.5%.) They have a variety of contracts they are still working on.

A fair amount of their business is geared towards the health side of life. One at $25 million contract with Newfoundland and are bidding on a couple of others. Quebec contract may be awarded in September. If they get this one, it could boost their earnings by 8/12% for 2007.

Has a backlog and is gearing up to the health side. Analysts are expecting earnings of $.04 this Friday. Earnings for 06 are expected to increase from $.16 to $.25 in 07.

Has unfortunately had a revolving door of management over the last 4 years. Ranked 547 out of 700 stocks in his database model. Earnings are suffering, but are expected to improve from a loss of $0.21 to a loss of $0.02 in '05. Sales have gone down by 33% year over year. Earnings are forcast to be $0.01 in '06. Against a stock of $3, it puts a PE multiple in excess of 200 X.

About 64% owned by BCE. Have seen about 10 quarters in a row of declining revenues.